TestoAlto
Natural health product licensed in Canada
- Licence holder
- R and D Healthcare Inc
- NPN or DIN-HM
- 80129095
- Status
- Active licence
- Licence date
- 19 January 2024
- Revision date
- 14 April 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B6 | 10 mg | Not calculated |
| 3,3'-Diindolylméthane Source : 3,3'-diindolylméthane | 37.5 mg | Not calculated |
| Eurycoma longifolia Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 2,000 mg | 200 mg | Not calculated |
| Magnésium Source : Acétate de magnésium | 200 mg | Not calculated |
| Zinc Source : Carbonate de zinc | 15 mg | Not calculated |
| Ophiocordyceps sinensis | 250 mg | Not calculated |
| Piper nigrum Source : Piper nigrum - fruit | 7 mg | Not calculated |
| Trigonella foenum-graecum Source : Trigonella foenum-graecum - Graine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 mg | 50 mg | Not calculated |
| Withania somnifera Source : Withania somnifera - racine Extract : Matériel brut sec Extraction ratio : 7:1 Dry plant equivalent : 350 mg | 50 mg | Not calculated |
| Rhodiola rosea Source : Rhodiola rosea - Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 mg | 50 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Poudre d'enveloppes d'Oryza sativa (Riz), Stéarate de magnésium, Hypromellose, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Hommes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Mineral supplement. Helps to support testosterone production. Helps to promote testosterone production.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80129095
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging